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Previous experiments have demonstrated  that  chloramphenicol can inhibit 
protein synthesis in mammalian  cell-free  systems as effectively as it inhibits 
protein synthesis in analogous microbial systems (1, 2).  Significant  inhibition 
occurs only when protein synthesis is stimulated by adding additional template 
RNA to ribosomes, there being comparatively little inhibition of protein syn- 
thesis in the absence of added stimulatory RNA. It was postulated from these 
studies that chloramphenicol may inhibit the function of messenger RNA by 
preventing its attachment to ribosomes. 
Recently  Ambrose  and  Coons  demonstrated  that  chloramphenicol  also 
inhibits protein synthesis by intact mammalian cells in vitro (3). These authors 
demonstrated that chloramphenicol can inhibit antibody synthesis in cultures 
of lymph node fragments and suggested that chloramphenicol  might exert its 
inhibitory effect by blocking the function of messenger RNA formed in response 
to the antigenic stimulus. 
The present studies were undertaken to determine whether chloramphenico] 
would inhibit de novo protein synthesis in vivo following antigenic stimulation. 
The data demonstrate that chloramphenicol can markedly suppress the primary 
immune  response  in  rabbits  without  substantially  modifying  a  subsequent 
analImestic  response  and  that  chlorarnphenicol  can  prolong  the  survival  of 
skin  homografts.  The  observations  are  in  accord  with  the  hypothesis  that 
chloramphenicol suppresses antibody synthesis by interfering with the function 
of messenger RNA. 
Material and M ahods 
White New Zealand rabbits and grey chinchilla rabbits weighing between 2 and 3 kg were 
maintained in individual cages on Purina rabbit chow and tap water.  In addition, 2 black 
and white rabbits were used in homotransplantation experiments. 
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Chloramphenicol  I was prepared as a  suspension with carboxymethyl cellulose in 0.75 per 
cent NaC1 in the proportion of I gm of chloramphenicol and 10 mg of carboxymethyl cellulose 
in 3 ml of 0.75 per cent NaC1. The chloramphenicol suspension was injected intramuscularly 
in the desired dosage with half the daily dose being administered at 12-hour intervals. In all 
instances, chloramphenicol was administered 24 hours prior to initiating the antigenic stimulus. 
Humoral Antibody Syntkesis.--The  response of rabbits to antigenic stimulation was deter- 
mined in control and experimental groups as shown in Tables I  to III. The effect of chlor- 
amphenicol on both the primary immune response and on the secondary response was deter- 
mined. 
Primary immune responses were studied in the following groups of animals: (a) 10 control 
animals on a standard diet; (b) 5 control animals, starved; (c) 9 animals receiving chloramphen- 
icol 0.15 to 0.30 gm per kg for 10 days;  (d)  18 animals receiving chloramphenicol 0.5 to 0.6 
gm per kg for 10 to 14 days (Table II). 
Anamnestic responses were determined in the following groups of animals:  (a)  8 control 
animals that had a normal primary response; (b) 12 animals whose primary immune response 
had been suppressed by chloramphenicol; (c)  9  animals receiving chloramphenicol 0.5  gm 
per kg for 10 days at the initiation of the secondary response (Table III). 
Antibody synthesis was induced by injecting 4  mg of alum-precipitated bovine gamma 
globulin (BGG)  (fraction II) into each hindfoot-pad. Animals were bled from marginal ear 
veins at appropriate intervals; the serum was separated and stored at --20°C until assayed. 
Antibody assays were performed by the tanned, formalinized erythrocyte hemagglutination 
technique described by Daniel et al.  (4). The amount of antibody was expressed in terms of 
dilution titer of the sera or as a  reciprocal of the dilution titer.  Serum levels of free chlor- 
amphenicol were determined on all samples by a modification of the method of Glazko et al. 
(5) previously described (6). 
The animals were weighed twice weekly. Hemoglobin, hematocrit, leukocyte count, reticulo- 
cyte count, and differential counts were obtained twice weekly while the animals were receiv- 
ing chloramphenicol. 
The type of antibody synthesized by animals with delayed and partially suppressed immune 
responses was determined by ultracentrifugation of sera in sucrose gradients by the method 
of Edelman et al. (7). Determinations were performed on the sera of the 1 rabbit manifesting 
incomplete suppression of primary antibody synthesis and on the sera of the 4 rabbits with 
delayed and suppressed anamnestic responses. 
Ski)) Homografts.--Transplants  were performed using skin from rabbit ears and in all but 
4 instances the transplants were made from albino rabbits to grey chinchilla rabbits or v/ce 
versa. The remaining transplants were exchanged between albino and black and white rabbits. 
Administration of chloramphenicol was begun 24 hours before transplanting the grafts and 
was continued in varying amounts and for varying periods as shown in Table I. Circular full 
thickness skin grafts, 2.5 cm in diameter, were dissected simultaneously from paired albino 
and grey chinchilla rabbits and exchanged. Grafts were sutured in place with 8 to 10 silk 0000 
sutures. No dressings were applied. The homografts were inspected daily and survival of the 
grafts readily determined by gross changes consisting of hemorrhage with subsequent harden- 
ing and eschar formation (Figs. 1 a and 1 b). 
The effect of varying the dose and duration of administration of chloramphenicol on the 
survival of the skin homografts was determined in 24 animals and compared with the survival 
of skin homografts in control groups consisting of 19 animals. The following groups of animals 
were studied:  (a)  12 control animals on a  standard diet; (b)  7 control animals, starved; (c) 
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6 animals receiving 0.15 to 0.30 gm per kg of chloramphenicol daily for 10 days; (d) 16 animals 
receiving 0.5 to 0.6 gm per kg of chloramphenicol daily for 11 to 14 days; (e) 2 animals receiving 
ehloramphenicol 0.6 gm per kg daily for 21 days (Tables I and IV). In 21 of the animals, the 
ability of ehloramphenicol to  modify both circulating  antibody s3rnthesis and homograft 
survival was determined simultaneously by injecting BGG when the homografts were trans- 
planted (Table 1). 
TABLE I 
The  Effect  of Chloramphenicol on  ttomografts  Survival  and  on  Primary Antibody  Response 
Itomograft survival 
Chloramphemlcol 
Amo~t 
gin/day 
0.6 
0.6 
0.6 
0.6 
0.5 
0,5 
0.5 
0,5 
0,5 
0.5 
0.5 
0.5 
0,5 
0.5 
0.5 
0,5 
0.5 
0.5 
0.5 
0.5 
0,6 
0,3 
0.3 
0.15 
0.15 
0.15 
0.15 
0,25 
0,25 
0,25 
t Duratio___~n 
14 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
10 
10 
10 
10 
10 
10 
10 
10 
I0 
Meaa Serum 
Levels 
ug/mt 
12.9 
11.0 
20.2 
17.5 
12,1 
8.7 
4.7 
11.5 
16.2 
12.9 
10.5 
13,8 
8.7 
11.4 
13.8 
8,5 
16.4 
6.4 
10.8 
11.1 
17.5 
7,2 
4.8 
1.9 
4,2 
4,1 
7.5 
Not done 
tt  ¢~ 
Graft Survival 
days 
>27* 
>28* 
20 
>26* 
Day Rejected 
after ehloramph. 
di~eontlnued 
>5 
>7 
6 
>12 
Primary immune response 
Anfi-BGG tlter 
(max) 
0 
0 
0 
0 
12 
17 
22 
18 
21 
25 
46 
18 
16 
14 
16 
26 
24 
20 
Not done 
15 
15 
9 
8 
10 
10 
Not done 
0 
5 
10 
6 
9 
13 
34 
6 
4 
2 
4 
14 
12 
8 
5 
5 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Not done 
~t  tc 
~c  4, 
0 
0 
0 
0 
1/166 (20 days) 
0 
0 
0 
1/40 (20 days) 
1/40 (14 days) 
1/160 (11 days) 
1/160 (10 days) 
1/320 (8 days) 
1/320 (11 days) 
1/40  (20 days) 
1/1280 (II days) 
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RESULTS 
Effect  of Ch2orampk~ico!  on  Primary  Antibody  Response.--The  effects  of 
chloramphenicol on  the primary immune  response are summarized in Tables 
I  and II and  in Text-fig.  1.  Normal antibody responses were  obtained in  10 
TABLE II 
The Effect of Chloramphenicol on the Primary Immune Response 
No chloramphenicol  (normal diet) 
No chloramphenicol  (starved) 
Chioramphenicol,  0.15-0.30 gm/kg, 10 
days 
Chloramphenicol,  0.5-0.6 gm/kg, 10-14 
days 
No. of 
rabbits 
10 
5 
9 
18 
Primary immune response 
Normal 
Normal 
Complete suppression  (1) 
Slight suppression  (8) 
Complete suppression  (17) 
Partially  suppressed  and  delayed 
(1) 
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T~xT-FzG. 1.  Suppression of primary antibody response with chloramphenlcol.  Complete 
suppression of the primary antibody response was observed in 17 out of 18 rabbits receiving 
chloramphenico] in a dosage of 0.5 to 0.6 gm daily for 12 days (B). Average values calculated 
from the geometric mean of all values are plotted. Only one of the 18 rabbits developed meas- 
urable circulating antibody (C). Compared to the normal primary immune response (A), this 
response was delayed and slightly suppressed. Ultracentrifugation studies in sucrose gradients 
demonstrate that the initial antibody formed in the delayed response (C) is 19S in type. A.  S.  WEISBERC-ER~ T.  M.  DANIEL)  AND  A.  HOI~'MAN  187 
rabbits on a standard diet, with circulating antibody detectable on the 6th day 
after injection of BGG and a maximum titer on the 10th day (mean titer 1//320, 
range 1/80  to 1/640).  Since animals receiving chloramphenicol  in the dosage 
employed in these experiments frequently lost weight, antibody formation was 
determined in an additional control group of 5 animals who were starved for a 
10 day period. These animals also manifested normal antibody responses. No 
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TEXT-FIG.  2.  Effect of smaller doses of chloramphenicol on the primary immune response. 
Smaller doses of chloramphenieol (0.15 to 0.3 gm per kg daily for 10 days) were almost com- 
pletely ineffective in suppressing  antibody response in 9  rabbits.  Complete suppression  of 
detectable circulating antibody was observed in only 1 rabbit (B). A slight suppression and a 
slight delay in appearance  of antibody was demonstrable in 8 of  the  9  rabbits  (C)  when 
compared to the normal primary immune response (A). 
antibody formation was detectable over a 4 week period  in 17 of 18 rabbits 
receiving chloramphenicol in a dosage of 0.5 to 0.6 gm per kg for 10 to 14 days 
(Text-fig.  1,  B).  The serum levels of free chloramphenicol  in these animals 
ranged from 4.7 to 20.2 #g per ml with a mean value of 12.6 #g per ml. A de- 
layed and partially suppressed primary antibody response occurred in 1 of the 
18 rabbits (Text-fig.  1, C).  In this animal, antibody formation was first de- 
tected on the 14th day and a maximum titer (1/160) was obtained on the 20th 
day. The mean serum chloramphenicol level in this rabbit was 10.8 #g per ml. 
In contrast, 8 of 9 animals receiving chloramphenicol in a dosage of 0.15 to 
0,3 gm per kg for 10 days exhibited a relatively insignificant suppression  of the 188  SUPPRESSION OF ANTIBODY SYNTHESIS 
TABLE III 
The  Effect of Chlorampkenicol  on  ttte Anamnestic  Response 
No  chloramphenicol  (normal  primary  immune re- 
sponse) 
No chloramphenieol (primary suppressed by chloram- 
phenicol) 
Chloramphenieol (normal primary immune response), 
0.5 gm/kg/day, 10 days 
No. of  I  __rablits 
12 
9 
Ananmestlc  response 
Normal 
Normal 
Slight dday and suppres- 
sion (5) 
Delayed  and  partially 
suppressed (4) 
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TEXT-lVIG. 3. Normal  anamnestie response after  suppression of primary response with 
chloramphenicol. The primary immune  response was completely suppressed by chlorampheni- 
col in 12 rabbits (A). These same 12 rabbits were given booster doses of antigen after 10 to 12 
weeks and exhibited an anamnestic response (B) which was indistingui~able  from that ob- 
tained in animals whose primary immune  response had not been inhibited by chloramphenicol 
(69. 
primary antibody response  (Tables  I  and H, Text-fig. 2).  Complete  suppres- 
sion of antibody formation was observed in only 1 of the 9 rabbits. This animal 
received 0.3 gm per kg of chloramphenicol per day for 10 days and had a mean 
serum-free  chloramphenicol  level of 7.2 #g per ml. The mean serum level of A. S. W'EISBERGER~  T. ~¢. DANIEL,  AND  A. HO]~PMAN  189 
free chloramphenicol in all animals of this group was 5.9 #g per ml (range 1.9 to 
7.5 tzg per ml). 
Twelve animals which had a  complete suppression of the primary immune 
response with chloramphenicol were challenged with a second injection of BGG 
to determine whether the resulting antibody synthesis, in the absence of chlor- 
amphenicol, would be primary or accelerated in type (Table III). The second 
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T]~xz-FIo. 4. The effect of chloramphenicol  on anamnestic responses. Administration of 
chloramphenicol in a dosage of 0.5 gm per kg per day for 10 days delayed and partially sup- 
pressed the anamnestic response in 4 of 9 rabbits (C). Only slight suppression of response 
occurred in 5 of the 9 rabbits (B). The normal anamnestic response in 8 rabbits is shown in 
curve A. 
antigenic stimulus was given i0 to 12 weeks after the initial injection of antigen, 
at a time when all chloramphenicol had been excreted. Each of these animals 
responded  with  a  typical  anamnestic  response.  Circulating  antibody  was 
detectable by the 3rd day with a peak value (mean titer 1/1280, range 1/640 to 
1/2560) between the 4th and 6th days (Text-fig. 3, B). The anamnestic response 
in these animals was almost identical with that obtained in 8 control animals 
(Text-fig. 3, C). 
The E~ect  of Chloramphenicol on  the Anamnestic  Response.--The  effect of 
chloramphenicol on the anamnesfic response is summarized in Table III and in 
Text-fig. 4.  Chloramphenicol administration was begun 24 hours before injec- 190  SUPPRESSION  OF  ANTIBODY  SYNTHESIS 
tion of the second antigenic stimulation. Two types of responses were noted. 
Four of 9 rabbits receiving chloramphenicol in a dosage of 0.5 gm per kg for 10 
days exhibited a  delayed and partially suppressed anamnestic response when 
challenged with a second antigenic stimulus (Text-fig. 4, B). Circulating anti- 
body was not apparent until the 7th day compared with appearance of antibody 
on the 3rd day in control animals  (Text-fig. 4, A). Peak antibody titers were 
found on the 16th or 17th day compared with the peak on the 4th day in control 
animals. The mean maximum titer was 1/160 (range 1/80 to 1/320) in animals 
receiving chloramphenicol  compared  to  1/1280  (range  1/640  to  1/2560)  in 
control animals.  Five of the 9 rabbits receiving chloramphenicol exhibited a 
slight delay and suppression in the anamnestic response Text-fig. 4,  C). The 
TABLE IV 
Survival of Skin Homografls in Rabbits Receiving Chloramphenivol 
No chloramphenicol (standard diet) ................. 
No chloramphenicol (starved) ..................... 
Chloramphenicol, 0.15-O.30 gm/kg/day,  10 days ..... 
Chloramphenicol, 0.5-0.6 gm/kg/day,  11-14 days .... 
Chloramphenicol, 0.6 gm/kg/day,  21 days .......... 
No. of animals 
12 
7 
6 
16 
2* 
Survival of homograft 
Range 
days 
6-8 
6-9 
8-15 
12-46 
27-28* 
Mean 
days 
7 
7.5 
11 
22 
27.5 
* These animals died without rejecting the homograft. 
serum level of free chloramphenicol in these animals ranged from 2.5 #g per ml 
to 8.2 #g per ml with a mean value of 5.5 #g per ml. There was no significant 
difference in serum chloramphenicol levels in the two groups of animals. 
The effect of Chloramphenicol  on Survival of Skin Homografts.--The effect of 
chloramphenicol on the homograft reaction is summarized in Tables I  and IV 
and in Text-fig. 5. Twelve animals on a normal diet rejected skin transplants 
within 6 to 8 days (mean, 7 days). Seven animals that were starved for 10 days 
and had weight losses comparable to those observed in animals receiving chlor- 
amphenicol, rejected skin grafts in 6 to 9 days (mean, 7.5 days). Sixteen rabbits 
receiving chlorarnphenicol in a dosage of 0.5 to 0.6 gm per kg for 10 to 14 days 
rejected their skin grafts in 12 to 46 days  ~ (mean 22 days). The serum level of 
free chloramphenicol in these animals ranged from 4.7 to 20.2/~g per ml with 
a mean value of 15.8 #g per ml. Two rabbits which received chloramphenicol 
in the dosage of 0.6 gm per kg for 21 days died without rejecting the homograft. 
Death was due to a ruptured viscus in both instances. Most animals rejected 
2 One animal died with severe diarrhea on the 26th day with the homograft intact. A. S. W~ISBERGER~  T. ~. DANIEL~ AND  A. HO]~FMAN  191 
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TSxT-FIG.  5.  Summary data on survival of skin homografts in rabbits. All control ~n;mah 
rejected skin grafts in 6 to 9 days (mean, 7 days). Animals receiving chloramphenlcol 0.15 to 
0.30 gm per kg for 12 days rejected skin grafts in 8 to 15 days (mean, 11 days). Animals re- 
ceiving chloramphenicol 0.5 to 0.6 gm per kg for 12 days rejected skin grafts in 12 to 46 days 
(mean, 22 days). 
TABLE  V 
Hemalologic Changes during Chloramphenlcol Therapy 
Hematocrit ............................ 
Reticulocyte count ..................... 
Leukocyte count ....................... 
Lymphocytes (absolute count) ........... 
Granulocytes (absolute count) ........... 
Mean initial values  Mean values during therapy 
37 per cent 
5.6 per cent 
8750 cells/ram  8 
3850 cells/ram  8 
4885 cells/ram  8 
30 per cent 
3.6 per cent 
9550 cells/ram  8 
5750 cells/ram  8 
2960 cells/ram  8 
the homografts 6 to 13 days after chloramphenicol was discontinued. In only 
one instance was the graft rejected while the animal was receiving chloramphen- 
icol. Graft rejection in control animals and graft survival in chloramphenicol- 
treated rabbits are illustrated in Figs. 1 a and 1 b and Figs. 2 a and 2 b. 192  SUPPRESSION  OF  ANTIBODY  SYNTHESIS 
Six rabbits which received chloramphenicol in a dosage of 0.15 to 0.30 gm per 
kg for 10 days rejected skin grafts in 8 to 15 days (mean 11 days). Serum levels 
of free chloramphenicol ranged from 1.9 to 7.5 #g per ml in these animals with 
a mean value of 5.9 gg. 
Most  of the  animals  were  moderately anorectic while  receiving chloram- 
phenicol. Changes in weight ranged from -0.4 to -4-0.15 kg with an average 
loss of 0.15 kg in the animals receiving 0.5 to 0.6 gm per kg of chloramphenicol. 
With the exception of the 2 animals who died after receiving chloramphenicol 
for 21 days and the 1 animal who died with fulminating diarrhea, all animals 
rapidly regained their appetites and appeared to be normal in health. 
TABLE VI 
Type of Antibody Synthesized in  Animals with Delayed Responses 
Primary response  Secondary response 
Day  19S  7S  Day  19S  7S 
15 
20 
26 
per ceni 
ioo 
82 
41 
per ~ent 
18 
50 
7 
15 
18 
21 
per ~:e~i~ 
15 
5 
$ 
2 
per cent 
85 
95 
95 
98 
The type of antibody synthesized by animals with delayed and partially suppressed im- 
mune responses was determined by ultracentrffugation of sera in sucrose gradients. Hemag- 
glutination titers were plotted against the distance of antibody sedimentation through the 
gradient and the relative percentage of antibody calculated by estimating the area under the 
7S and  19S portions of the curve obtained. 
In the 1 animal with a delayed primary response, the initial antibody was of the 19S vari- 
ety. In the 4 animals with delayed secondary responses, the initial antibody response was of 
the 7S variety. 
Hematologic  and Serum Protein Changes with Chloramphenicol.--In the dosage 
employed,  chloramphenicol  usually  produced  a  modest  fall  in  hematocrit, 
reticulocytes,  and  granulocytes without  any  significant  change  in  the  total 
leukocyte count (Table V). Studies performed by ultracentrifugafion in sucrose 
gradients on sera from the 1 animal whose primary immune response was not 
completely suppressed,  revealed a  normal primary type of response (8)  with 
respect to the sequence of appearance  of 19S  and  7S  antibodies,  the initial 
antibody being of the 19S variety (Table VI). The initial antibody response in 
the 4 animals whose anamnestic response was partially delayed and suppressed 
by chloramphenicol was the 7S variety (Table VI). 
DISCUSSION 
The data demonstrate that  chloramphenicol can suppress primary hemag- 
glutinating antibody synthesis in vivo without affecting the ability of the animals A. S. WEISBERGER,  T. M. DANIEL,  AND  A. HOFFMAN  193 
subsequently to  develop a  normal  anamnestic  response.  Although  complete 
suppression of the primary antibody response was observed, it is possible that 
some antibody synthesis occurred which was not detectable by the assay tech- 
nique employed. The subsequent prompt development of a normal anamuestic 
response indicates that cells were prepared for antibody synthesis during  the 
period that chloramphenicol suppressed the synthesis of circulating antibody. 
These findings are in accord with the hypothesis that chloramphenicol  inhibits 
de novo  mammalian protein synthesis by blocking  the function of messenger 
RNA without directly affecting DNA or RNA synthesis (2, 3). 
Antibody formation implies  that messenger  RNA capable of directing the 
synthesis of specific protein must be formed and deposited on ribosomes. In the 
preceding report (2) it was demonstrated that chloramphenicol  probably pre- 
vents the attachment of messenger RNA to ribosomes and thereby prevents its 
function in cell-free systems. This may be the mechanism by which chloram- 
phenicol also suppresses antibody formation in vivo. The results of these experi- 
ments are in accord with the observations of Ambrose and  Coons (3)  on the 
inhibition by chloramphenicol of antibody synthesis by intact mammalian cells 
in vitro.  These findings  indicate that  the inhibitory effect of chloramphenicol 
on de novo  protein  synthesis may be applicable  to mammalian  cells  in  vivo 
as well as to cell-free systems and intact cells in vitro.  Although there is a pos- 
sibility that the results are due to reversible hypoplasia of antibody-producing 
cells, no clear evidence of such hypoplasia was found in histologic  sections of 
spleen,  lymph  nodes,  gastrointestinal  tract,  pulmonary  lymph  follicles,  or 
marrow of 4 animals receiving  chloramphenicol  in a dosage of 0.5 gm per kg. 
In particular there was no cellular degeneration such as is seen with the use of 
irradiation, alkylating agents, or purine analogs. 
Chloramphenicol  was more effective in suppressing  the primary immune re- 
sponse than in suppressing  the anamnestic response in vivo. Ambrose and Coons, 
however, were able to obtain complete inhibition  of the secondary antibody 
response with low levels of chloramphenicol  in vitro. The reasons for this discrep- 
ancy are not clear. Chloramphenicol  may be more effective in vitro because more 
intimate contact with proliferating ceils is possible and because the absence of 
detoxification mechanisms permits a more sustained level than is possible in 
vivo.  Other factors such as the rapidity of protein synthesis and the number of 
cells involved in synthesis may account for the relative ineffectiveness  of chlor- 
amphenicol in inhibiting the anamnestic response in vivo.  Conceivably higher 
levels of serum chloramphenicol  might have been more effective in suppressing 
the secondary response. 
Fahri and Lamensans published a preliminary report alleging that chloram- 
phenicol inhibits antibody synthesis in rabbits  (10). These studies have been 
justly criticized  by Schwartz and Andr4 (11) on the grounds that the observed 
effects were minimal and that one tube differences in agglutination titers were 
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per kg body weight in their studies. According  to our data this dosage is fax 
below the minimal effective amount required to suppress antibody synthesis. 
Optimum  results  in  our  experiments were obtained when 0.5  gm per kg of 
chloramphenicol  were  employed.  Dosages  of chloramphenicol  between 0.15 
and 0.3 gm per kg were almost completely ineffective in suppressing antibody 
responses. 
The mechanism of action of chloramphenicol  in suppressing immune responses 
differs markedly from that of other immunosuppressive drugs thus far studied 
(11-16).  Purine and pyrimidine analogs,  folic acid analogs,  actinomycin, and 
nitrogen  mustard  all  inhibit  cell  growth  and  suppress  antibody formation. 
Interference with nucleic acid synthesis appears to be the predominant action 
of these drugs and probably the means by which they suppress antibody syn- 
thesis (17). Despite the difference in mechanism of action, the effects of chloram- 
phenicol and 6-mercaptopurine  (6 MP)  on antibody synthesis are similar  in 
many respects. Thus 6 MP in a dosage of 6 mg per kg blocks the primary anti- 
body response without affecting  the secondary response.  6 MP also prolongs 
homograft survival as long as the drug is administered. The chief difference in 
the effect of 6 MP compared to chloramphenicol  lies in the ability of 6 MP to 
produce a state of tolerance when sufficiently  large doses (18 mg per kg) are 
administered  to rabbits  (16).  Probably this  effect of 6 MP is  related  to its 
ability to  interfere  with  the  synthesis  of nucleoproteins  controlling  cellular 
information.  Chloramphenicol  does not directly affect nucleoprotein synthesis 
and therefore it would not seem likely that tolerance could be achieved with this 
drug. However, relatively prolonged survival of homografts after chloramphen- 
icol  was discontinued  in  some of the  animals  suggests that  some degree of 
tolerance may have been achieved by an as yet undetermined mechanism. 
The duration of chloramphenicol  administration was important in suppressing 
antibody synthesis in relation to persistence of antigen. The primary immune 
response was completely inhibited by administering chloramphenicol  for 10 to 
12 days, possibly because adequate antigenic stimulation did not persist beyond 
this period. Homograft rejection tended to occur 6 to 13 days after chloram- 
phenicol  was discontinued, probably because the antigenic homograft was still 
present to stimulate an immune response.  In all instances in which 0.5 gm of 
chloramphenicol  per kg was used, suppression  of the primary immune response 
was observed in association with prolonged survival of homografts. However, in 
no instance did a rise in humoral antibody titer occur following graft rejection. 
The prolongation of homograft survival by chloramphenicol  is in accord with 
the prevailing  concept  that  homograft  rejection is  mediated by an  immune 
mechanism,  and the effectiveness  of chloramphenicol  in prolonging  homograft 
survival indicates that synthesis of protein is involved in the rejection phenom- 
enon. 
On a  weight basis,  the  amount  of chloramphenicol  administered  to  these 
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However, the ability of rabbits to detoxify or excrete chloramphenicol appears 
to be much greater than that of humans. Thus, it should be noted that the 
serum levels of free chloramphenicol attained in  these rabbits were approxi- 
mately 2 to 4  times the therapeutic levels ordinarily attained in humans.  It 
seems quite likely that some of the higher chloramphenicol levels represent an 
excess of the amount necessary to obtain inhibition. For example, inhibition of 
the primary immune response was obtained with serum levels of free chloram- 
phenicol only slightly greater than therapeutic blood levels in humans. Further- 
more, no greater survival of homografts was observed with serum chloramphen- 
icol levels of 16 to 20/~g per ral than could be obtained with serum levels of 8 to 
15/zg per ml. It is apparent, however, that better results were obtained with 
0.5  gm of chloramphenicol per kg than with 0.15 to 0.3 gm per kg and that 
serum levels of free chloramphenicol above 8 ~g per rnl were in general necessary 
for optimum results. 
The ability of chloramphenicol to suppress antibody synthesis by inhibiting 
de novo  protein synthesis adds another drug to the immunosuppressive com- 
pounds which may have usefulness in studying the mechanisms  of antibody 
synthesis. Combined use of these drugs may shed further light on the processes 
involved and may have some therapeutic applications. 
SUMMARY 
Chloramphenicol  suppresses  primary  antibody  synthesis  in  vivo  without 
affecting the ability to develop a normal anamnestic response. Chloramphenicol 
also  prolongs homograft  survival  in  rabbits.  The  survival  of homografts is 
related to the duration as well as to the amount of chloramphenicol adminis- 
tered.  The mechanism  of action  of chloramphenicol in  suppressing  immune 
responses is correlated with its ability to inhibit protein synthesis in proliferating 
mammalian  cells.  These  observations  suggest  that  the  inhibitory  effect of 
chloramphenicol on protein synthesis may be applicable to mammalian cells 
in vivo as well as to cell-free systems and to intact mammalian cells in vitro. 
We are indebted to Dr. Richard Moore and to Dr. Melvin Schoenberg  of the Department 
of Pathology for interpreting the histologic  sections. 
We wish to thank E. Ceasar Moss and Charlotte Terlak for their technical assistance. 
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EXPLANATION  OF PLATES 
PLATE 19 
FIG. 1 a.  Rejection of skin homografts in 2 control animals on the 7th day. Grafts 
exchanged between albino and grey chinchilla rabbits. 
FIG. 1 b.  Beginning  rejection of skin  homograft in  animal on left and continued 
survival of skin homograft in animal on right after 18 days. Grafts exchanged between 
albino and grey chinchilla rabbits. Both animals received chloramphenicol  0.5 gm per 
kg daily for 12 days. THE  ~OURNAL  OF  EXPERIMENTAL MEDICINE  VOL.  120  PLATE  19 
(Weisberger et al.: Suppression of antibody synthesis) PLATE 20 
FIGS. 2 a and 2 b.  Continued  survival  of  homografts  in  rabbits  after  21  days. 
Grafts exchanged between albino and black and white rabbits. Both animals received 
chloramphenicol 0.5 gm per kg daily for 12 days. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 120  PLATE 20 
(Weisberger et al.: Suppression of antibody synthesis) 